You can buy or sell UROV and other stocks, options, ETFs, and crypto commission-free!
Urovant Sciences Ltd. Common Stock, also called Urovant Sciences, is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Read More Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Expected Nov 12, After Hours